Selection of an ICRF-187-resistant CHO cell line and measurement of cytotoxicity, additive cytotoxicity, and cross-resistance of bisdioxopiperazines, anthracyclines, and other antineoplastic agents in wildtype and resistant cells

Similar Items

• Selection of an ICRF-187-resistant CHO cell line and measurement of cytotoxicity, additive cytotoxicity, and cross-resistance of bisdioxopiperazines, anthracyclines, and other antineoplastic agents in wildtype and resistant cells
  by: Kuschak, Theodore I.
  Published: (2013)
• Development of water-soluble prodrugs of the bisdioxopiperazine topoisomerase IIβ inhibitor ICRF-193 as potential cardioprotective agents against anthracycline cardiotoxicity
  by: Hana Bavlovič Piskáčková, et al.
  Published: (2021-02-01)
• Emergence of cytotoxic resistance in cancer cell populations*
  by: Lorenzi Tommaso, et al.
  Published: (2015-01-01)
• Curcumin Nanoparticles and Their Cytotoxicity in Docetaxel-Resistant Castration-Resistant Prostate Cancer Cells
  by: Irin Tanaudommongkon, et al.
  Published: (2020-07-01)
• Studies on the mechanism of induced resistance to antitumour agent ICRF 159 in mammalian cell lines
  by: Kenwrick, Susan Jane
  Published: (1984)